J. Kevin Buchi - 10 May 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
10 May 2024
Transactions value $
$0
Form type
4
Date filed
14 May 2024, 16:41
Previous filing
06 May 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +76.5K +41.19% 262K 10 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -76.5K -100% $0.00* 0 10 May 2024 Class A Common Stock 76.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 On May 9, 2023, the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024.